PT  - JOURNAL ARTICLE
AU  - Walaa A. Aldarwish
AU  - Eman N. Ali
TI  - Effects of intrathecal Baclofen in reducing tremors in patients with multiple sclerosis
AID  - 10.17712/nsj.2023.2.20220102
DP  - 2023 Apr 01
TA  - Neurosciences Journal
PG  - 148--150
VI  - 28
IP  - 2
4099  - http://nsj.org.sa/content/28/2/148.short
4100  - http://nsj.org.sa/content/28/2/148.full
SO  - Neurosciences (Riyadh)2023 Apr 01; 28
AB  - Symptomatic treatment of Multiple Sclerosis (MS) is crucial, since it helps to lessen the limitations that affect patients’ daily lives. Tremors are a significant and frequent symptom in MS patients. However, there is still a lack of evidence supporting a specific therapeutic approach for MS patients’ tremors. A 41-year-old man with a history of MS is presented in this study. He exhibited stiffness and tremors at the follow-up clinic, which affected his daily activities. For his spasticity, he received intrathecal baclofen (ITB). The patient’s symptoms responded well to this treatment, as both stiffness and tremors decreased. In an MS patient, ITB therapy thus unexpectedly reduced and improved tremor symptoms.